Neurocrine Biosciences, Inc. (NBIX)

NASDAQ: NBIX · Real-Time Price · USD

157.21

-1.21 (-0.76%)

At close: May 18, 2026, 4:00 PM EDT

157.51

+0.30 (0.19%)

Pre-market: May 19, 2026, 6:52 AM EDT

Neurocrine Biosciences Revenue by Segment

Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Ingrezza	2.63B	2.51B	2.47B	2.40B	2.35B	2.31B	2.20B	2.07B
Ingrezza Growth	11.60%	8.66%	12.40%	15.74%	21.80%	26.00%	26.72%	27.42%
Collaboration and Other	22.00M	26.60M	25.90M	26.40M	27.30M	24.70M	26.20M	27.70M
Collaboration and Other Growth	-19.41%	7.69%	-1.15%	-4.69%	-1.44%	-6.79%	1.16%	0.73%
Ongentys and Other Products	15.10M	19.10M	19.80M	18.30M	18.20M	17.20M	18.00M	20.40M
Ongentys and Other Products Growth	-17.03%	11.05%	10.00%	-10.29%	-19.82%	-30.08%	-21.74%	3.03%

Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.